Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Uxin (UXIN) Cash & Equivalents (2016 - 2025)

Uxin filings provide 10 years of Cash & Equivalents readings, the most recent being $11.7 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 234.76% to $11.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.7 million, a 234.76% increase, with the full-year FY2025 number at $11.9 million, up 245.06% from a year prior.
  • Cash & Equivalents hit $11.7 million in Q4 2025 for Uxin, up from $10641.5 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.4 billion in Q3 2023 to a low of $3424.0 in Q3 2022.
  • Median Cash & Equivalents over the past 5 years was $10.6 million (2025), compared with a mean of $132.1 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 99.99% in 2022 and later soared 71183495.21% in 2023.
  • Uxin's Cash & Equivalents stood at $23.4 million in 2021, then crashed by 99.94% to $15088.0 in 2022, then skyrocketed by 17711.98% to $2.7 million in 2023, then surged by 30.08% to $3.5 million in 2024, then soared by 234.76% to $11.7 million in 2025.
  • The last three reported values for Cash & Equivalents were $11.7 million (Q4 2025), $10641.5 (Q3 2025), and $9.5 million (Q2 2025) per Business Quant data.